BridgeMD
New treatment option for Substance Use Disorders
Official title Improving Social Functioning in People With Substance Use and Mental Health Disorders Using VR
ClinicalTrials.gov ID: NCT06677515
What this study is testing
- What it's testing
- ROPVR, a multi-centre, pragmatic randomized controlled trial (RCT) aims to evaluate a VR-technology which has been developed within an exploratory study and a development study, which facilitates social functioning among persons with a substance use and mental health disorder. Investigators will test a VR-program versus treatment as usual among patients enrolled into a long-term addiction-treatment facility.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- adults aged 18 years or older receiving in-patient SUD treatment in specialized addiction treatment units in South-East Norway. This may include...
- having the capability to read, understand and sign the Norwegian informed consent form
- willing and able to attend VR training two times a week for 5 weeks
You likely can't join if
- significant visual, auditory, or balance impairment or other diseases affecting safety during VR sessions (e.g., epilepsy)
- current clinically significant severe mental health disorder (e.g., acute episode of psychosis or current active suicidal plans). Persons with...
- severe travel sickness as a proxy for simulation sickness
The study team makes the final eligibility decision.
Where it's taking place
- Brumunddal, Norway
- Hamar, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brumunddal, Norway; Hamar, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.